Li Menghua, Zhou Sen, Dong Guofu, Wang Changzhen
Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing 100850, P.R. China.
Department of Biochemistry, Basic Medical College of Anhui Medical University, Hefei, Anhui 230032, P.R. China.
Oncol Lett. 2024 Oct 11;28(6):602. doi: 10.3892/ol.2024.14735. eCollection 2024 Dec.
A novel radiotherapy (RT) approach termed FLASH-RT, which irradiates areas at ultra-high dose rates, is of current interest to medical researchers. FLASH-RT can maintain equivalent antitumor effects while sparing healthy tissue compared with conventional RT (CONV-RT), which uses low dose rates. The sparing effect on healthy tissue after FLASH-RT is known as the FLASH effect. Owing to the FLASH effect, FLASH-RT can raise the maximum tolerable dose to control tumor growth or eradicate the tumor and provide a new strategy for clinical RT. However, definitive irradiation conditions for reproducing the FLASH effect and the biological mechanism of the FLASH effect have not yet been fully elucidated. The efficacy of FLASH-RT is controversial despite its successful application in clinical RT. The present review recapitulates the progression of FLASH-RT and critically comments on the hypothesis of the FLASH effect. In addition, the review expounds on the current issues with regard to the differential phenomena between and studies, and elaborates on the challenges for the application of FLASH-RT that need to be addressed in the future.
一种名为FLASH-RT的新型放射疗法(RT)目前受到医学研究人员的关注,它以超高剂量率照射区域。与使用低剂量率的传统放疗(CONV-RT)相比,FLASH-RT在保护健康组织的同时能维持等效的抗肿瘤效果。FLASH-RT后对健康组织的保护作用被称为FLASH效应。由于FLASH效应,FLASH-RT可以提高控制肿瘤生长或根除肿瘤的最大耐受剂量,并为临床放疗提供一种新策略。然而,重现FLASH效应的明确照射条件以及FLASH效应的生物学机制尚未完全阐明。尽管FLASH-RT已成功应用于临床放疗,但其疗效仍存在争议。本综述概述了FLASH-RT的进展,并对FLASH效应的假说进行了批判性评论。此外,该综述阐述了关于[此处原文缺失相关对比研究内容]研究之间差异现象的当前问题,并详细说明了未来应用FLASH-RT需要解决的挑战。